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http://dx.doi.org/10.1016/j.stemcr.2016.07.004SUMMARYSkeletalmuscle contains two distinct stem/progenitor populations. One is the satellite cell, which acts as amuscle stem cell, and the other
is the mesenchymal progenitor, which contributes to muscle pathogeneses such as fat infiltration and fibrosis. Detailed and accurate
characterization of these progenitors in humans remains elusive. Here, we performed comprehensive cell-surface protein profiling of
the two progenitor populations residing in human skeletal muscle and identified three previously unrecognized markers: CD82 and
CD318 for satellite cells and CD201 for mesenchymal progenitors. These markers distinguish myogenic and mesenchymal progenitors,
and enable efficient isolation of the two types of progenitors. Functional study revealed that CD82 ensures expansion and preservation of
myogenic progenitors by suppressing excessive differentiation, and CD201 signaling favors adipogenesis of mesenchymal progenitors.
Thus, cell-surface proteins identified here are not only useful markers but also functionally important molecules, and provide valuable
insight into human muscle biology and diseases.INTRODUCTION
Skeletal muscle is an organ responsible for movement or
physical activity, and therefore is vital for healthy life. Skel-
etalmuscle ismainly composed ofmultinucleated cylindri-
cal myofibers. Myofibers are terminally differentiated cells,
and the cell cycle of their nuclei is irreversibly arrested.
However, skeletal muscle regenerates well if myofibers are
damaged and undergo necrosis. Skeletal muscle regenera-
tion is attributable to the function of satellite cells that
reside between the basal lamina and plasma membrane of
myofibers. Satellite cells are normally quiescent, but
rapidly become activated after muscle damage and prolifer-
ate extensively to produce myoblasts. Myoblasts then
differentiate and fuse with each other or damaged my-
ofibers to regenerate muscle. Some myoblasts remain un-
differentiated and return to the quiescent state tomaintain
the satellite cell pool. Thus, satellite cells play a central
role in muscle regeneration by acting as muscle stem cells
(Bischof, 2004).
Skeletal muscle is also a site where pathological develop-
ment of ectopic tissues occurs. Adipose tissue, fibrous con-Stem Cell
This is an open access article under the Cnective tissue, or even bone can be ectopically formed
within muscle not only in muscular disorders but also in
other pathological conditions (Uezumi et al., 2014b).
Because myofibers are terminally differentiated cells, they
cannot be the source of these ectopic tissues. Hence, how
these ectopic tissues emerge from skeletal muscle was a
long-standingmystery. The identification of mesenchymal
progenitors solved this mystery. We and others have iden-
tified mesenchymal progenitors distinct from satellite cells
in mouse skeletal muscle and have shown that these
mesenchymal progenitors contribute to ectopic adipose
tissue (Joe et al., 2010; Uezumi et al., 2010), fibrous connec-
tive tissue (Uezumi et al., 2011), and heterotopic ossifica-
tion (Wosczyna et al., 2012). Therefore, satellite cells and
mesenchymal progenitors are indispensable cell types for
studying skeletal muscle regeneration and pathogenesis,
respectively.
Given that satellite cells and mesenchymal progenitors
are strongly associated withmuscle regeneration and path-
ogenesis, identifying, distinguishing, and isolating these
two progenitor populations in human skeletal muscle
are of considerable clinical significance. Compared withReports j Vol. 7 j 263–278 j August 9, 2016 j ª 2016 The Author(s). 263
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Cell-Surface Protein Profiling of Human Skeletal Muscle-Derived Progenitors by Antibody Screening
(A) Scheme of antibody screening.
(B) Expanded CD56+ cells and PDGFRa+ cells were stained with antibodies against MYOD1 and PAX7. The percentages of positive cells are
shown in the panels as means ± SD, n = 5 randomly selected fields. Scale bar, 50 mm.
(C) Distinctive markers identified by antibody screening.
(D) Primary human skeletal muscle-derived cells were stained with antibodies against CD56, PDGFRa, and a newly identified marker. CD56+
(red) and PDGFRa+ (blue) gates were set by analyzing negative control samples stained with an isotype control antibody or secondary
reagent only.
(legend continued on next page)
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mouse, studies dealingwith progenitor cells of human skel-
etal muscle are limited. In human satellite cells, only Pax7,
M-cadherin, integrin a7, and CD56 have been considered
to be specific markers (Boldrin et al., 2010; Castiglioni
et al., 2014). Although Pax7 is a reliable marker for satellite
cells in both mouse and human tissues (Boldrin and Mor-
gan, 2012), this marker is not suitable for cell isolation
because of its nuclear localization. M-cadherin has been re-
ported to successfully identify human satellite cells (Bol-
drin and Morgan, 2012; Reimann et al., 2004; Sajko et al.,
2004). We also identified satellite cells on human muscle
sections using M-cadherin antibody (Uezumi et al.,
2014a), but this antibody cannot be used for isolation of
human myogenic cells. CD56 is the only marker that en-
ables isolation of human satellite or myogenic cells, as
distinguished from mesenchymal progenitors with adipo-
genic potential, known so far (Agley et al., 2013; Castiglioni
et al., 2014; Uezumi et al., 2014a). Several markers have
been reported to identify mesenchymal progenitors in hu-
man skeletal muscle. CD15 (Lecourt et al., 2010; Pisani
et al., 2010a) and CD34 (Pisani et al., 2010b; Vauchez
et al., 2009) were used to isolate cells with adipogenic po-
tential, but adipogenic cells were also found in CD15 or
CD34 populations of human muscle-derived cells (Agley
et al., 2013; Castiglioni et al., 2014). A recent study reported
the isolation of a mesenchymal stem cell-like population
from human muscle-derived cells as CD73+CD105+CD90
cells (Downey et al., 2015). However, this study did not
investigate myogenic cells; thus, whether these markers
can isolate mesenchymal cells separately from myogenic
satellite cells remains unclear. We know only platelet-
derived growth factor receptor a (PDGFRa) as a marker
that has been successfully used to isolate mesenchymal
progenitors as being distinct from myogenic satellite cells
from human skeletal muscle (Arrighi et al., 2015; Uezumi
et al., 2014a).
To gain further insight into progenitor cells derived from
human skeletal muscle, we performed comprehensive cell-
surface protein profiling of two progenitor populations,
CD56+ myogenic progenitors and PDGFRa+ mesenchymal
progenitors. This comprehensive analysis identified previ-
ously unrecognized markers: CD82 and CD318 for satellite
cells and CD201 for mesenchymal progenitors. Immuno-
fluorescent staining revealed that CD82 and CD318 are
expressed on sublaminar satellite cells, and CD201 is ex-(E) Expressions of indicated markers on CD56+ cells were analyzed. The
PDGFRa+ cells as the negative population (blue). The percentages of
means ± SD, n = 13 for CD82, n = 4 for CD271, and n = 15 for CD318.
(F) Expression of CD201 on PDGFRa+ cells was analyzed. The PDGFRa+
cells as the negative population (red). The percentage of positive c
SD, n = 6.
See also Figures S1–S4.pressed on interstitial mesenchymal progenitors in vivo.
Isolated CD82+ or CD318+ cells showed high myogenic
potential, while adipogenic potential was enriched exclu-
sively in the CD201+ population. Finally, CD82 knock-
down resulted in premature differentiation at the expense
of expansion and self-renewal of myogenic progenitors,
and stimulation of CD201 signaling facilitated adipogenic
differentiation of mesenchymal progenitors. Therefore,
cell-surface proteins identified in this study are not only
useful markers for cell identification and isolation but
also functionally important molecules that regulate myo-
genesis and adipogenesis of human satellite cells and
mesenchymal progenitors, respectively.RESULTS
Cell-Surface Protein Profiling of Human Skeletal
Muscle-Derived Progenitors by Antibody Screening
We previously reported the isolation of myogenic and
mesenchymal progenitors from human skeletal muscle as
CD56+ and PDGFRa+ cells, respectively, and showed that
physiological oxygen concentration has significant impact
on growth of cells derived from human muscle (Uezumi
et al., 2014a). We further optimized culture conditions for
efficient expansion of isolated cells and found that collagen
I coating and basic fibroblast growth factor (bFGF) promote
proliferation of human muscle-derived progenitors (Fig-
ure S1). This condition allowed these progenitors to
expand in vitro to 1 3 108 cells, which in turn enabled us
to perform cell-surface protein profiling by antibody array.
This analysis is based on the staining of cell-surface pro-
teins with 332 antibodies and subsequent fluorescence-
activated cell sorting (FACS) analysis (Figure 1A). We
confirmed that expanded CD56+ cells maintained the
myogenic progenitor state, as revealed by PAX7 and
myogenic differentiation 1 (MYOD1) positivity, and their
surface phenotype as CD56+PDGFRa (Figures 1B and
1C). On the other hand, PDGFRa+ cells maintained
their non-myogenic nature and surface phenotype as
CD56PDGFRa+ cells (Figures 1B and 1C). The entire
dataset of CD56+ cells and PDGFRa+ cells is shown in
Figures S2 and S3, respectively. We first looked at previ-
ously reported markers that were used to isolate
myogenic or mesenchymal progenitors from humanCD56+ population is shown in red. Positive gates were set by using
positive cells in the CD56+ population are shown in the panels as
population is shown in blue. A positive gate was set by using CD56+
ells in the PDGFRa+ population is shown in the panel as means ±
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muscle. Charville et al. (2015) recently reported the isola-
tion of human satellite cells using epidermal growth factor
receptor (EGFR) as a marker, but we found that EGFR is
expressed in both cultured myogenic and mesenchymal
progenitors (Figures S2 and S3). Immunofluorescent stain-
ing of human muscle revealed that EGFR is indeed ex-
pressed by satellite cells but is also expressed bymany inter-
stitial cells (Figure S4A). Furthermore, interstitial PDGFRa+
mesenchymal progenitors do express EGFR (Figure S4B),
indicating that thismarker cannot distinguish satellite cells
from mesenchymal progenitors. CD15 (Lecourt et al.,
2010; Pisani et al., 2010a), CD34 (Pisani et al., 2010b; Vau-
chez et al., 2009), CD73 (Downey et al., 2015), CD90
(Downey et al., 2015), and CD105 (Downey et al., 2015)
were used to isolate mesenchymal progenitors, but all of
these markers were found to be distributed equally on
both cultured myogenic and mesenchymal progenitors
(Figures S2 and S3).
We then searched formarkers that are expressed differen-
tially between two types of progenitors, and found that
CD82, CD274, and CD318 are selectively expressed on
cultured myogenic progenitors while CD201 is preferen-
tially expressed on culturedmesenchymal progenitors (Fig-
ure 1C). Next, we confirmed results of antibody screening
by analyzing primary cells derived from human skeletal
muscle. CD82 and CD318 clearly distinguished CD56+
myogenic progenitors from PDGFRa+ mesenchymal pro-
genitors, and the opposite could be achieved by using
CD201 (Figures 1D and 1E). Because expression of CD274
was too weak to discriminate the two progenitors, we
omitted this marker in the subsequent experiments (Fig-
ures 1D and 1E).
Expression of CD82, CD318, and CD201 in Human
Skeletal Muscle Tissue
In vivo expression of identified markers was examined by
using human muscle sections. Membrane expression of
CD82 was clearly observed on PAX7+ or M-cadherin+ satel-
lite cells in normal human muscle (Figures 2A and 2B).
CD82 expression was found in almost all satellite cells
(97.2% ± 0.6%:mean ± SD, n = 3 different healthy subjects,
total number of satellite cells examined = 205). CD82 was
predominantly expressed by satellite cells in muscle tissue,Figure 2. Expression of Discovered Markers in Adult Human Skele
(A and B) Adult human muscle sections were stained with antibodi
laminin (B). Arrowheads indicate satellite cells located beneath the
(C and D) DMD muscle sections were subjected to immunofluorescent s
Arrows indicate centrally nucleated M-cadherin+ myofibers.
(E) Adult human muscle sections were stained with antibodies agains
interstitial spaces, and arrowheads indicate satellite cell located ben
(F) DMD muscle sections were stained with antibodies against CD201
Scale bars represent 10 mm (A–D) and 20 mm (E and F). See also Figualthough we observed a small number of interstitial cells
expressing CD82 (data not shown). We next examined
Duchenne muscular dystrophy (DMD) muscle sections
to investigate the expression of CD82 on activated
satellite cells in vivo. CD82 signals were well overlapped
on M-cadherin+ activated satellite cells and also on M-cad-
herin+ centrally nucleated nascentmyofibers in DMDmus-
cles (Figures 2C and 2D). These results indicate that CD82 is
expressed on human satellite cells and its expression lasts
until the early differentiation phase, but disappears as my-
ofibers mature. A similar expression pattern was observed
when human muscle sections were stained with antibody
against CD318 (Figures S4C and S4E), although the
percentage of positive satellite cells was relatively low
(74.6% ± 5.6%;mean ± SD, n = 3 different healthy subjects,
total number of satellite cells examined = 253), and cyto-
plasmic expression was also pronounced. In contrast to
CD82 and CD318, CD201 antibody clearly recognized
interstitial cells as distinguished from sublaminar PAX7+
satellite cells (Figure 2E). CD201+ cells could be seen with
high frequency around blood vessels (Figure 2E). When
DMD muscle sections were stained with anti-CD201 anti-
body, a considerable accumulation of CD201+ cells was
conspicuous in the areas of fibrosis where aberrant accumu-
lation of collagen was observed (Figure 2F).
Isolation of Human Myogenic and Mesenchymal
Progenitors Using Discovered Markers
To determine the efficacy of identified markers for progen-
itor cell isolation, we stained human muscle-derived cells
with antibodies against CD82, CD318, or CD201. Staining
with these markers resulted in clear separation of positive
and negative populations (Figure 3A). If cell sorting was
performed on the basis of CD82 or CD318 expression,
PAX7+MYOD1+ myogenic progenitors were found only in
CD82+ or CD318+ fractions (Figures 3B and 3C). When
they were induced to differentiate into myotubes, many
myosin heavy chain (MyHC)+ myotubes developed only
from CD82+ or CD318+ cells (Figure 3D). We next exam-
ined adipogenic differentiation after cell sorting based on
CD201 expression. We detected adipogenic activity
exclusively in CD201+ cells (Figure 3E). Isolated CD201+
cells were uniformly positive for CD201 in the growthtal Muscle and DMD Muscle
es against CD82, PAX7, and laminin (A) or CD82, M-cadherin, and
basement membrane.
taining for CD82 and M-cadherin, and subsequently to H&E staining.
t CD201, PAX7, and laminin. Arrows indicate CD201+ cells located in
eath the basement membrane.
and collagen I.
re S4.
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condition, but in the adipogenic condition, expression of
CD201 disappeared from differentiated adipocytes and
was maintained in only a few undifferentiated cells (Fig-
ure 3F). Likewise, ectopic adipocytes developed within
skeletal muscle were also negative for CD201 (Figure 3G),
suggesting a link between expression of CD201 and the un-
differentiated state. These results indicate that markers
identified by cell-surface protein profiling are useful for effi-
cient isolation of progenitor cells from human muscle. We
also examined the expression of identified markers in
commercially available human skeletal muscle myoblast
(HSMM) cultures. CD56+ cells were strongly positive for
CD82, but expression of CD318 was reduced in HSMM cul-
tures (Figure S5A). When cell sorting was done on the basis
of CD56 and CD82 expression, myogenic cells were exclu-
sively found in the CD56+CD82+ fraction (Figures S5B–
S5D). Surprisingly, many PDGFRa+ non-myogenic cells
were present in HSMM cultures and were positive for
CD201 (Figure S5E). Adipogenic potential was detected
only in this PDGFRa+CD201+ fraction (Figure S5F). Thus,
markers described here are also useful in the purification
of progenitor cells from commercially available cultures.
These results prompted us to use discovered makers for
purifying myogenic progenitors from human induced
pluripotent stem cells (iPSCs). Human iPSCs (clone
253G4) (Nakagawa et al., 2008) were induced to differen-
tiate into myogenic cells as previously described (Fig-
ure S6A) (Hosoyama et al., 2014), and the induced cells
were examined for expression of CD82 and CD318.
Although CD318 was not detected, a CD82+ fraction was
readily identified in iPSC-derived cells (Figure S6B) and
CD82+ cells showed considerably high expression of
myogenic progenitor-related genes compared with other
fractions (Figure S6C), indicating that myogenic progeni-
tors are exclusively enriched in the CD82+ fraction of
human iPSC-derived cells. Similar results were obtained
when another iPSC line (clone 201B7) (Takahashi et al.,
2007) was used (Figure S6D). To further explore the useful-Figure 3. Efficient Isolation of Myogenic Progenitors by CD82 or
(A) Primary human skeletal muscle-derived cells were stained with a
negative fractions. Sorting gates are shown in the panels.
(B and C) The indicated cell populations were cultured in the growth c
and PAX7. The percentages of positive cells are shown in the panels
(D) The indicated cell populations were cultured in the myogenic di
against myosin heavy chain (MyHC).
(E) The indicated cell populations were cultured in the growth conditio
Cells were stained with antibodies against perilipin and C/EBPa. Num
n = 15 fields from three independent preparations.
(F) CD201+ cells grown in growth condition or subjected to the adip
perilipin.
(G) Human muscle samples with ectopic adipocytes were subjected t
quently to H&E staining.
Scale bars, 50 mm. See also Figures S5 and S6.ness of CD82 as a myogenic marker, we divided iPSCs
(clone 454E2) (Okita et al., 2011) induced to a myogenic
lineage into four fractions based on the expression of
CD82 and CD56 (Figure S6E). After cell sorting, we found
that myotube forming activity was highly enriched in
CD82+CD56+ cells (Figure S6F). Thus, CD82 is a useful
myogenic marker that is applicable to the isolation of
myogenic progenitors not only from human skeletal
muscle but also from human iPSCs.
In Vivo Myogenic Potential of CD82+ Cells or CD318+
Cells, and Fibrogenic/Adipogenic Potential of
CD201+ Cells
The in vivo myogenic potential of CD82+ or CD318+ cells
isolated from humanmuscle was evaluated by transplanta-
tion into injuredmuscles of immunodeficientmice. Fifteen
days after transplantation, many human spectrin+ myofib-
ers that contain human lamin+ nuclei were observed in the
muscles that had received CD82+ or CD318+ cells (Figures
4A and 4B; Table 1). In addition to differentiatedmyofibers,
occasional human Lamin+ and PAX7+ sublaminar satellite
cells could be detected in CD82+ or CD318+ cell-trans-
planted muscles (Figure 4C and Table 1), indicating that
transplanted CD82+ or CD318+ cells possess self-renewal
potential. Such in vivo myogenic activity was detected in
all CD82+ or CD318+ populations prepared from four inde-
pendent samples, but rarely seen in CD82 or CD318 cells
(Table 1). To evaluate in vivo differentiation potential of
CD201+ cells, we permanently labeled CD201+ cells with
the fluorescent protein Venus by using lentiviral vector.
We confirmed that CD201+ cells were efficiently trans-
duced with Venus (Figure 4D), and Venus labeling did
not affect adipogenic differentiation (Figure 4E). After sort-
ing of Venus-labeled CD201+ cells, the cells were trans-
planted into glycerol-injured muscles of immunodeficient
mice. Two weeks after transplantation, many Venus+
cells were detected in fatty/fibrous degenerated areas and
some of them expressed peroxisome proliferator-activatedCD318 and Mesenchymal Progenitors by CD201
ntibodies against indicated markers and divided into positive and
ondition for 3 days and then stained with antibodies against MYOD1
as means ± SD, n = 15 fields from three independent preparations.
fferentiation condition for 5 days and then stained with antibody
n for 3 days, then cells were subjected to the adipogenic condition.
bers of adipocytes per field are shown in the panels as means ± SD,
ogenic condition were stained with antibodies against CD201 and
o immunofluorescent staining for CD201 and perilipin, and subse-
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Figure 4. In Vivo Myogenic Potential of CD82+ Cells or CD318+ Cells, and Fibrogenic/Adipogenic Potential of CD201+ Cells
(A–C) The indicated cell populations were transplanted into CTX-injured muscles of immunodeficient mice. Transplanted muscle sections
were subjected to immunofluorescent staining for human lamin A/C, human spectrin, and laminin a2 (A, B), or human lamin A/C, PAX7,
and laminin a2 (C). Arrows indicate lamin A/C+PAX7+ human satellite cells located beneath the basement membrane.
(legend continued on next page)
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Table 1. Summary of Transplantation Experiment
Patient
Cell
Type
Number of
Transplanted Cells
Number of Lamin
A/C+ Cells/Section
Number of Spectrin+
Myofibers/Section
Number of Lamin
A/C+PAX7+ Cells/Section
Hu36 CD82+ 8 3 104 45 23 0
CD82+ 8 3 104 20 10 3
CD82+ 8 3 104 35 20 3
CD82 5 3 104 90 2 0
CD318+ 7 3 104 125 70 9
CD318+ 7 3 104 50 28 7
CD318+ 7 3 104 61 25 3
CD318 5 3 104 66 0 0
Hu37 CD82+ 6 3 104 70 16 0
CD82+ 6 3 104 57 13 1
CD82 6 3 104 352 0 0
CD82 6 3 104 109 0 0
CD82 6 3 104 220 0 0
Hu38 CD82+ 1 3 105 12 7 1
CD82+ 1 3 105 12 3 0
CD82 1 3 105 26 0 0
CD82 1 3 105 15 0 0
Hu39 CD318+ 1 3 105 55 14 2
CD318+ 1 3 105 35 15 1
CD318 1 3 105 179 1 0
CD318 1 3 105 19 0 0receptor g (PPARg) (Figure 4F), suggesting the functional
importance of these cells in muscle pathogenesis.
FunctionofCD82 andCD201 inHumanMyogenic and
Mesenchymal Progenitors
We explored roles of discovered markers in the regulation
of progenitor function. Because CD82 is consistently ex-
pressed myogenic cells from human muscle, commercially
available cells, and iPSCs, we knocked down CD82 in
CD56+CD82+ myogenic cells purified from human muscle
by small interfering RNA (siRNA). Almost complete knock-
down of CD82 was confirmed at both mRNA and protein(D) CD201+ cells transduced with Venus were analyzed by fluorescent
(E) Venus-labeled CD201+ cells were stained with antibodies against
(F) Venus-labeled CD201+ cells were transplanted into glycerol-injure
were stained with antibodies against GFP and PPARg. Arrow indicate
Scale bars represent 20 mm (A and B), 10 mm (C and F), 100 mm (D),levels (Figure 5A). Intriguingly, knocked-down CD82 cells
showed reduced proliferation and increased MYOD1 and
MYOG transcript level even under growth condition
(Figures 5B and 5C). Although the percentage of MYOD1+
cells remained unchanged, the percentage of myogenin
(MYOG)+ cells and the total amount of MYOD1 and
MYOG protein were dramatically increased in knocked-
down CD82 cells (Figures 5D–5F), indicating that CD82
knockdown leads to premature differentiation. Because
p38 signaling is well known to be involved in myogenic
differentiation, we examined this signaling pathway. Phos-
phorylation of p38 was increased upon CD82 knockdownmicroscope and FACS.
GFP and PPARg.
d muscles of immunodeficient mice. Transplanted muscle sections
s Venus+ adipocyte expressing PPARg.
and 50 mm (E).
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Figure 5. Knockdown of CD82 Leads to Premature Differentiation in Myogenic Progenitors at the Expense of Expansion and
Reserve Cell Generation
(A) CD56+CD82+ cells were purified and cultured. Cells were transfected with negative control siRNA (NC) or CD82 siRNA (CD82KD). The
indicated cells were cultured in the growth condition for 2 days. The expression of CD82 mRNA was quantified by qRT-PCR. Values are
represented as the ratio to control cells and shown as means ± SD of three independent preparations. *p < 0.01 (left). The expression of
CD82 protein was measured by FACS (right).
(legend continued on next page)
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(Figure 5G), and the excessive upregulation ofMYOD1 and
MYOG induced by CD82 knockdown was suppressed by
p38 inhibitor (Figure 5H), suggesting that CD82 inhibits
premature differentiation at least in part by attenuating
the p38 signaling pathway. When induced to differentiate
into myotubes, knocked-down CD82 cells showed a signif-
icant decrease in the levels of PAX7 andMYOD1 transcript
but maintained increased MYOG expression (Figure 5I).
Knocked-down CD82 cells exhibited extravagant differen-
tiation (Figure 5J) and reduced the number of reserve cells
compared with control cells (Figure 5K). These results
suggest that CD82 is required for achieving an appropriate
balance between differentiation and self-renewal of human
myogenic progenitors.
CD201 acts as a receptor for protein C (PC) and activated
protein C (APC). CD201 forms a complex with PC and
thrombomodulin (TM) to exert its major function, antico-
agulation, but also initiates diverse intracellular signaling
in the presence of co-receptor protease-activated receptor
1 (PAR1) upon APC binding (Mohan Rao et al., 2014).
When analyzed by FACS, PAR1 was found to be expressed
strongly on the surface of human mesenchymal progeni-
tors, although only faint expression of TM was detected
(Figure 6A), which suggests that mesenchymal progenitors
can elicit signals throughCD201-PAR1 receptors upon APC
binding. To gain insight into the role of CD201 signaling in
mesenchymal progenitors, we added APC to the medium
during adipogenic differentiation. Although the total
number of cells remained unchanged (data not shown),
adipocyte formation was significantly enhanced in the
presence of APC (Figures 6B and 6C). However, mesen-
chymal progenitors showed no adipogenesis when treated
with the medium containing APC but not adipogenic-
inducing reagents (Figure 6D), suggesting that CD201
signaling per se cannot initiate adipogenesis but reinforces(B) Cell proliferation was measured by using WST-8 reagent and show
(C) The expressions of myogenic genes were quantified by qRT-PCR.
means ± SD of four independent preparations. *p < 0.01, **p < 0.05
(D and E) Cells were stained with antibodies against MYOD1 or MYOG.
fields from four independent preparations. *p < 0.01
(F) Western blot analysis of MYOD1, MYOG, and GAPDH. Results from
(G) Phosphorylation of p38 was assessed by immunoblotting. Results
(H) Control or knocked-down CD82 cells were treated with SB203580
analyzed by immunoblotting. Results from two independent preparat
(I) After 2 days of culture in growth condition, cells were induced to d
quantified by qRT-PCR. Values are represented as the ratio to control c
*p < 0.01.
(J) The indicated cells were stained with antibody against MyHC and t
control cells and are shown as means ± SD of three independent prep
(K) The indicated cells were stained with antibody against sarco
undifferentiated reserve cells. The percentages of reserve cells are sho
*p < 0.01.
Scale bars represent 50 mm (D, E, K) and 100 mm (J).the adipogenic program evoked by other inductive cues.
Akt and Erk are important signaling pathways that
enhance central the adipogenic program governed by
PPARg (Peng et al., 2003; Prusty et al., 2002). When treated
with APC, both Akt and Erk pathways were activated in
mesenchymal progenitors (Figure 6E). Our data suggest
that CD201 signaling favors adipogenesis through acti-
vating Akt and Erk pathways in mesenchymal progenitors.DISCUSSION
In this study, we comprehensively analyzed the cell-surface
phenotype of two types of progenitor cells residing in hu-
man skeletal muscle. As a consequence, we identified three
previously unknown cell-surface markers: CD82 and
CD318 for myogenic progenitors and CD201 for mesen-
chymal progenitors. In human muscle tissue, sublaminar
satellite cells express both CD82 and CD318, and intersti-
tialmesenchymal progenitors express CD201. Intriguingly,
these markers can distinguish between myogenic and
mesenchymal progenitors, and are applicable to efficient
isolation of the two types of progenitor cells. Considering
the limited information about progenitor cells residing in
human skeletal muscle, our comprehensive analysis
provides profound insight into their characteristics by
defining the cell-surface phenotype of myogenic pro-
genitors as CD56+CD82+CD318+PDGFRaCD201 and
that of mesenchymal progenitors as CD56CD82
CD318PDGFRa+CD201+.
CD82, also known as KAI1, is a member of the tetraspa-
nin family. Although tetraspanins are involved in a wide
variety of biological processes such as cell adhesion, migra-
tion, proliferation, and signal transduction (Liu and Zhang,
2006), CD82 is probably best known as a metastasisn as means ± SD of three independent preparations. *p < 0.01.
Values are represented as the ratio to control cells and shown as
.
The percentages of positive cells are shown as means ± SD, n = 20
two independent preparations are shown.
from two independent preparations are shown.
(p38i) or DMSO. The expression of MYOD1, MYOG, and GAPDH was
ions are shown.
ifferentiate into myotubes. The expressions of myogenic genes were
ells and are shown as means ± SD of four independent preparations.
he MyHC+ area was quantified. Values are represented as the ratio to
arations. *p < 0.01.
meric a-actinin, PAX7, and Ki67. Arrows indicate PAX7+Ki67
wn as means ± SD, n = 9 fields from three independent preparations.
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Figure 6. CD201 Signaling Facilitates Adipogenesis of Mesenchymal Progenitors
(A) The cell-surface expression of TM and PAR1 was analyzed by FACS. Isotype control is shown in blue and antibody-stained sample in red.
(B) Mesenchymal progenitors were induced to differentiate into adipocytes with (Adipo + APC) or without (Adipo) APC. Lipid droplets were
stained with Bodipy.
(C) Adipocyte differentiation was quantified by measuring Bodipy+ area per cell. Values are represented as the ratio to cells not treated with
APC and shown as means ± SD of three independent preparations. *p < 0.01.
(D) Mesenchymal progenitors were cultured in 10% FBS/DMEM (Cont), 10% FBS/DMEM supplemented with APC (APC), or adipogenic
differentiation condition (Adipo). Adipocyte differentiation was quantified, and values are represented as the ratio to control cells and
shown as means ± SD of three independent preparations. *p < 0.01.
(E) Mesenchymal progenitors were serum starved overnight and then stimulated with APC for 30 min. Phosphorylation of Akt and Erk were
assessed by immunoblotting.suppressor (Dong et al., 1995). Expression of CD82 was
reported in many non-muscle tissues (Custer et al., 2006;
Huang et al., 1997; Nagira et al., 1994), and low-level
expression of CD82 was also detected in skeletal muscle
(Custer et al., 2006; Nagira et al., 1994). However, the
detailed expression pattern of CD82 in skeletal muscle
has not been examined. In this study, we demonstrated
that CD82 is expressed on satellite cells in normal human
skeletal muscle and on activated satellite cells or small re-
generating myofibers in DMD muscle, but is absent in
mature myofibers. Expression of CD82 seems to be specific
to immature myogenic cells in human skeletal muscle
because only a few CD82+ cells could be seen in the inter-
stitial spaces. Specific expression of CD82 inmyogenic cells
is further supported by a microarray study of mouse satel-274 Stem Cell Reports j Vol. 7 j 263–278 j August 9, 2016lite cells (Fukada et al., 2007) that showed high-level
expression of CD82 in satellite cells compared with non-
myogenic cells (Table S1). Such specificity provides signifi-
cant value as a marker, because other markers used for the
isolation of human satellite cells such as CD29 and EGFR
(Charville et al., 2015; Xu et al., 2015) are also expressed
in non-myogenic cells. Knockdown experiments revealed
that CD82 suppresses premature differentiation by inhibit-
ing MYOD1 and MYOG expression in human myogenic
progenitors. We further showed that knocked-down
CD82 cells exhibited excessive differentiation at the
expense of generation of reserve cells, which represent an
in vitromodel of self-renewal. AlthoughCD82 has received
scant attention in stem cell biology, recent study demon-
strated an important role for this cell-surface molecule in
maintaining hematopoietic stem cell (HSC) quiescence
(Hur et al., 2016), which is suggestive of a general role for
CD82 in stem cell maintenance. Our data suggest that
CD82 exerts its effects on myogenic progenitors through
attenuating p38 signaling, although we cannot exclude
other mechanisms that mediate CD82 functions. Precise
mechanisms whereby CD82 suppresses MYOD1 and
MYOG, and thereby ensures expansion and self-renewal
of human myogenic progenitors, are of great interest.
CD318, also known as CUB domain-containing pro-
tein 1, acts as a substrate for Src family kinases and is
associated with the metastatic potential of cancer cells
(Wortmann et al., 2009). In addition to cancer cells,
CD318 has been reported to be present in several stem/pro-
genitor populations such as hematopoietic stem/progeni-
tor cells, mesenchymal stem cells, and neural progenitor
cells (Buhring et al., 2004; Conze et al., 2003; Takeda
et al., 2010). We reported here that CD318 is also expressed
on human myogenic progenitors with an expression
pattern similar to that of CD82. However, expression of
CD318 was diminished in commercially available myo-
blasts and undetectable in iPSC-derived cells. Although
the exact reason for the downregulation of CD318 is
currently unknown, the oxygen concentration used in
those cultures differed from that in our culture condition.
We used a hypoxic condition for cell culture, but com-
mercially available myoblasts or iPSCs were cultured in a
normoxic condition. Because expression of CD318 is
induced by hypoxia (Cao et al., 2015; Emerling et al.,
2013; Razorenova et al., 2011), a different oxygen concen-
tration might lead to a difference in CD318 expression.
CD201, also known as endothelial protein C receptor, is
a type 1 transmembrane glycoprotein expressed in the
endothelium of large blood vessels and also in many other
cell types (Mohan Rao et al., 2014). Its well-known func-
tion is anticoagulation. Our analysis revealed that
CD201 is specifically expressed in mesenchymal progeni-
tors but not in myogenic satellite cells within human
skeletal muscle. While previously reported mesenchymal
markers such as CD15 (Lecourt et al., 2010; Pisani et al.,
2010a), CD34 (Pisani et al., 2010b; Vauchez et al.,
2009), CD73 (Downey et al., 2015), CD90 (Downey
et al., 2015), and CD105 (Downey et al., 2015) were
distributed equally on both cultured myogenic and
mesenchymal progenitors, our comprehensive analysis
identifies one of the most powerful markers, which is
equivalent to PDGFRa and can distinguish mesenchymal
progenitors from myogenic cells. We also found that
human mesenchymal progenitors highly express PAR1, a
co-receptor of CD201. CD201 is selectively expressed in
HSCs (Balazs et al., 2006), and CD201-PAR1 signaling
has been recently shown to regulate the retention and
recruitment of HSCs within the bone marrow microenvi-ronment (Gur-Cohen et al., 2015). We showed in this
study that stimulation of CD201-PAR1 signaling in
mesenchymal progenitors leads to enhanced adipogenesis
by activating the Akt and Erk pathway. Thus, our study
further unveils an additional function of CD201, which
is traditionally recognized as a coagulation-related factor,
as a regulator of stem/progenitor cell function.
In conclusion, we identified previously unrecognized
markers of two types of progenitor cells residing in human
skeletal muscle by comprehensive cell-surface protein
profiling. These markers are quite unique in being able to
distinguish between myogenic and mesenchymal progeni-
tors, and in regulating myogenesis and adipogenesis. Our
study provides meaningful information not only for the
basic science of human skeletalmuscle but also for practical
research, including regenerative medicine for muscle
diseases.EXPERIMENTAL PROCEDURES
Human Muscle Samples
Experiments using human samples were approved by the Ethical
Review Board for Clinical Studies at Fujita Health University.
Non-dystrophic muscle samples were obtained from gluteus
medius muscles of subjects undergoing total hip arthroplasty.
DMD muscle samples were obtained from muscle (rectus femoris
or biceps brachii) biopsies performed for diagnostic purposes.
A human myoblast culture was purchased from Lonza.
Dissociation of Cells from Muscle Samples
Muscles were transferred to PBS and digested with 0.2% type II
collagenase (Worthington). Muscle slurries were filtered through
a cell strainer (BD Biosciences). Cells were resuspended in growth
medium (GM) consisting of DMEM supplemented with 20%
fetal bovine serum (FBS), 1% penicillin-streptomycin, and
2.5 ng/mL bFGF (Katayama Chemical), seeded onto a collagen
I-coated dish (Iwaki), and maintained at 37C in 5% CO2
and 3% O2.
FACS
Cells were trypsinized and resuspended in washing buffer consist-
ing of PBS with 2.5% FBS, and stained with primary antibodies.
Cells were then stained with secondary reagents. Primary
antibodies and secondary reagents used are described in Supple-
mental Experimental Procedures. Stained cells were analyzed by
FACSVerse, FACSVantage SE (BD Biosciences), or MoFlo Astrios
(Beckman Coulter). Cell sorting was performed on a FACSVantage
SE or MoFlo Astrios.
Antibody Screening
After cell sorting, CD56+ cells or PDGFRa+ cells were cultured in
GM on a collagen I-coated dish at 37C in 5% CO2 and 3%
O2, and expanded to 1 3 10
8 cells. Antibody screening was
carried out using a LEGENDScreen human cell screening kit
(BioLegend).Stem Cell Reports j Vol. 7 j 263–278 j August 9, 2016 275
Cell Culture
Sorted cells were cultured on Matrigel-coated (BD Biosciences)
plates in GM at 37C in 5% CO2 and 3% O2. Ten thousand cells
were added per well. Myogenic and adipogenic differentiation
were carried out as described in Supplemental Experimental Proce-
dures. CD82 knockdown was performed by transfecting CD82
siRNA (Ambion). Cell proliferation was measured using Cell
Counting Kit-8 (Dojindo). SB203580 (Wako), a p38 inhibitor,
was used at 10 mM. APC (Haematologic Technologies) was used
at 100 or 1,000 nM.
iPSCs and Induction of Myogenic Progenitors
Human iPSCs were provided by the Center for iPS Cell Research
and Application. Myogenic cells were induced from iPSCs as
previously described (Hosoyama et al., 2014). Induced cells were
trypsinized and resuspended in washing buffer, then subjected to
FACS sorting.
Generation of Lentiviral Vector and In Vitro
Transduction
Plasmids required for generation of lentiviral vector were obtained
from RIKEN BRC. The lentiviral vector was generated as described
by Ikemoto et al. (2007). Sorted CD201+ cells were infected with
200 MOI of viral vector.
Transplantation Experiment
All procedures using experimental animals were approved by the
Institutional Animal Care and Use Committee at Fujita Health
University. Immunodeficient NOD/scid or NSG mice were used.
One day prior to transplantation, tibialis anterior (TA) muscles
were injured with cardiotoxin (CTX) or glycerol as described by
Uezumi et al. (2010). Cells in 25 mL of PBS were transplanted
into injured TA muscles. Fifteen days after transplantation, TA
muscles were sampled and subjected to histological analysis.
Histochemistry, Cytochemistry, and Microscopy
For CD82 and CD318 immunostaining, sections were treated with
Antigen Retrieval Reagent-Universal solution (R&D Systems) at
95C for 5 min. Specimens were blocked with protein-block
serum-free reagent (Dako) for 15 min, and incubated with primary
antibodies at 4C overnight, followed by secondary staining.
Antibodies used are described in Supplemental Experimental Pro-
cedures. Specimens were counterstained with DAPI (Invitrogen)
and mounted with SlowFade Gold anti-fade reagent (Invitrogen).
Stained samples were photographed using a fluorescence
microscope BX51 (Olympus), an inverted fluorescencemicroscope
BZ-9000 (Keyence), or an inverted fluorescence microscope
DMI4000B (Leica). Confocal images of muscle sections were taken
using the confocal laser scanning microscope system LSM700
(Carl Zeiss).
Immunoblotting
Cells were lysed in lysis buffer containing protease inhibitor
cocktail (Roche). For the detection of phosphorylated proteins,
phosphatase inhibitor cocktail (Roche) was added. Ten micro-
grams of protein was separated by SDS-PAGE and transferred276 Stem Cell Reports j Vol. 7 j 263–278 j August 9, 2016onto polyvinylidene difluoride membranes. The membranes
were probed with primary antibodies described in Supplemental
Experimental Procedures. After incubation with horseradish
peroxidase-conjugated secondary antibodies and chemilumines-
cence reactions, images of the developed immunoblots were
captured using a Light-Capture imaging system (ATTO).
Quantitative Analyses of Cultured Cell
Three to five randomly selected fields per well were photographed.
Images were collected and pooled from two or three independent
experiments. The purity of myogenic progenitors was determined
by dividing the number of myogenic marker+ cells by the number
of DAPI+ nuclei. To assess the efficiency of adipogenic differentia-
tion, we quantified the number of adipocytes per field or Bodipy-
stained area. MyHC+ area per well was quantified to assess the effi-
ciency of myogenic differentiation.
RNA Extraction and RT-PCR
Total RNA was extracted using an RNeasy Micro Kit (Qiagen), and
equal amounts of RNAwere reverse transcribed into cDNA using a
QuantiTect Reverse Transcription Kit (Qiagen). Real-time qPCR
was performed on a ThermalCycler Dice Real Time System (Takara)
or LightCycler 480 System (Roche). Specific primer sequences
used in this study are described in Supplemental Experimental
Procedures.
Statistics
The significance of differences among experimental groups was as-
sessed by Student’s t test or one-way ANOVA followed by Tukey’s
post hoc test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, and one table and can be found with this
article online at http://dx.doi.org/10.1016/j.stemcr.2016.07.004.
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